Clinical and serological evolution in chronic Chagas disease patients in a 4-year pharmacotherapy follow-up: a preliminary study

被引:21
|
作者
Andrade, Monica Coelho [1 ]
Oliveira, Maria de Fatima [2 ]
Nagao-Dias, Aparecida Tiemi [2 ]
Branco Coelho, Ivo Castelo [1 ]
Candido, Darlan da Silva [2 ]
Freitas, Erlane Chaves [1 ]
Luna Coelho, Helena Lutescia [3 ]
Moraes Bezerra, Fernando Schemelzer [1 ,2 ,4 ]
机构
[1] Univ Fed Ceara, Fac Med, Dept Patol & Med Legal, Fortaleza, Ceara, Brazil
[2] Univ Fed Ceara, Fac Farm, Dept Anal Clin & Toxicol, Fortaleza, Ceara, Brazil
[3] Univ Fed Ceara, Fac Farm, Dept Farm, Fortaleza, Ceara, Brazil
[4] Univ Fed Ceara, Fac Med, Dept Saude Comunitaria, Fortaleza, Ceara, Brazil
关键词
Benznidazole; Chagas disease; Pharmacotherapy follow-up;
D O I
10.1590/0037-8682-1646-2013
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Introduction: The role of trypanocidal therapy in the chronic phase of Chagas disease remains controversial. Methods: A total of 13 patients with chronic Chagas disease were treated with benznidazole (5mg/kg/day/60 days) and surveyed via antibody measurement and conventional electrocardiogram over the course of 4 years. Results: The antibody titers were signifi cantly reduced after 4 years (p<0.05). Most of the patients showed maintenance of the initial clinical picture (electrocardiographic), with the exception of 4 cases. Conclusions: Although trypanocidal therapy in the chronic phase of Chagas disease was of limited effectiveness, we believe that it is benefi cial in treating these patients.
引用
收藏
页码:776 / 778
页数:3
相关论文
共 33 条